Show
Sort by
-
- Journal Article
- A1
- open access
T Cell epitope mapping of the E-protein of West Nile virus in BALB/c mice
-
- Journal Article
- A1
- open access
Vaccine-induced protection of Rhesus macaques against plasma viremia after intradermal infection with a European lineage 1 strain of West Nile virus
-
- Journal Article
- A1
- open access
Vaccination of mice using the West Nile virus E-protein in a DNA prime-protein boost strategy stimulates cell-mediated immunity and protects mice against a lethal challenge
-
Innate immune response and programmed cell death following carrier-mediated delivery of unmodified mRNA to respiratory cells
-
- Journal Article
- A1
- open access
Immunogenicity of live attenuated B. pertussis BPZE1 producing the universal influenza vaccine candidate M2e
-
- Journal Article
- A1
- open access
M2e-displaying virus-like particles with associated RNA promote T helper 1 type adaptive immunity against influenza A
-
Polymeric multilayer capsule-mediated vaccination induces protective immunity against cancer and viral infection
-
- Journal Article
- A1
- open access
Recent progress in West Nile virus diagnosis and vaccination
-
Comparison of the gene transfer efficiency of mRNA/GL67 and pDNA/GL67 complexes in respiratory cells
-
Protection against H5N1 influenza by immunoglobulin single variable domains
-
Tick-borne encephalitis virus seropositive dog detected in Belgium: screening of the canine population as sentinels for public health
-
- Journal Article
- A1
- open access
Nanobodies with in vitro neutralizing activity protect mice against H5N1 influenza virus infection
-
Universal vaccine based on ectodomain of matrix protein 2 of Influenza A: Fc receptors and alveolar macrophages mediate protection
-
- Journal Article
- A1
- open access
Antiserum against the conserved nine amino acid N-terminal peptide of influenza A virus matrix protein 2 is not immunoprotective
-
M2e-based universal influenza A vaccine
-
Universal M2 ectodomain-based influenza A vaccines: preclinical and clinical developments
-
Universal influenza A M2e-HBc vaccine protects against disease even in the presence of pre-existing anti-HBc antibodies
-
Mx1 causes resistance against influenza A viruses in the Mus spretus-derived inbred mouse strain SPRET/Ei
-
An influenza A vaccine based on tetrameric ectodomain of matrix protein 2
-
Improved design and intranasal delivery of an M2e-based human influenza A vaccine